Targeted TLR9 Agonist Elicits Effective Antitumor Immunity against Spontaneously Arising Breast Tumors
Caitlyn L. Miller(Stanford University), Ronald Levy(Stanford Medicine)
Cited by 3
Related Papers
Targeting CD137 enhances the efficacy of cetuximab
|Journal of Clinical Investigation|2014|161